Zobrazeno 1 - 10
of 917
pro vyhledávání: '"Bemt, P."'
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Medication waste poses health, economic, and environmental challenges. However, the extent among patients living in rural areas is underexplored. This study assessed the proportion of prescribed medications remaining unused by pat
Externí odkaz:
https://doaj.org/article/3a2fc673a8d94b9f9a6059bd2ff3d8ef
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1779-1788 (2024)
Bas JW van de Steeg,1 Anne C Esselink,2 Hugo AJM de Wit,1 Cornelis Kramers,1 Bart JF van den Bemt3 1Department of Clinical Pharmacy, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands; 2Department of Internal Medicine, Canisius Wilhelmina Hospit
Externí odkaz:
https://doaj.org/article/e55ff5b714204dd9915d98aa6c4876ef
Autor:
Rehana N. Rahman, Suzanne Polinder, Bojan Nikolik, Amber E. Hoek, Marjo J. A. Janssen, Stephanie C. E. Schuit, Patricia M.L.A. van den Bemt, Fatma Karapinar-Çarkit
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objective To perform a cost study of pharmacist-led medication reviews in patients with an acute hospitalization for adverse drug events. Method Emergency department pharmacists performed medication reviews in patients hospitalized after vis
Externí odkaz:
https://doaj.org/article/86914ce11fe24c05a7a4f31b1c1586ab
Autor:
Andri Phoka, Bart J. F. van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 773-794 (2024)
Abstract Introduction Several barriers to optimal care in axial spondyloarthritis (axSpA) exist, which is detrimental to patient outcomes. The Rheumacensus programme aimed to identify how the standard of care (SoC) and treatment ambition for patients
Externí odkaz:
https://doaj.org/article/27cadfe747704201be19f397964cbf18
Autor:
Elisabeth M. Smale, Eva W. Verkerk, Eibert R. Heerdink, Toine C.G. Egberts, Bart J.F. van den Bemt, Charlotte L. Bekker
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 15, Iss , Pp 100493- (2024)
Background: Minimizing medication waste through the redispensing of oral anticancer drugs (OADs) that were unused by patients provides economic and environmental benefits, but this is not yet universally implemented in clinical care. Objective(S): To
Externí odkaz:
https://doaj.org/article/08df3f25dc9843aaaceebe8ab34c2a8b
Autor:
Carina M.E. Hansen, Anna J. Breukelman, Patricia M.L.A. van den Bemt, Annelies M. Zwitserloot, Liset van Dijk, Job F.M. van Boven
Publikováno v:
European Respiratory Review, Vol 33, Iss 173 (2024)
Background In the last decade, a fundamental shift in the treatment of cystic fibrosis (CF) took place due to the introduction of CF transmembrane conductance regulator (CFTR) modulators. Adequate medication adherence is a prerequisite for their effe
Externí odkaz:
https://doaj.org/article/01b9620030fd417298277fa99e2cbf09
Autor:
Mandy R. S. Hendrix, Mustafa Yasar, Atiya K. Mohammad, Jacqueline G. Hugtenburg, Joost W. Vanhommerig, Ruveyda Gündoğan-Yilmaz, Patricia M. L. A. van den Bemt, Petra Denig, Fatma Karapinar-Carkıt
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Prescribing cascades occur when patients are prescribed medication to treat the adverse drug reaction of previously prescribed medication. Prescription sequence symmetry analysis (PSSA) can be used to assess the association between two medic
Externí odkaz:
https://doaj.org/article/e976cda4c7ff499085ed53655cea47f5
Autor:
Nathan den Broeder, Aatke van der Maas, Alfons A den Broeder, Bart JF van den Bemt, Frank HJ van den Hoogen, Yael A de Man, Marc R Kok, Lise Verhoef, Rogier Thurlings, Wilfred van der Weele
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Background The REDO trial (REtreatment with Rituximab in RhEmatoid arthritis: Disease Outcome after Dose Optimisation) showed similar disease activity for retreatment with ultralow doses (200 mg and 500 mg per 6 months) compared with standard low-dos
Externí odkaz:
https://doaj.org/article/12646c2bca3040469a48a59a6f5fa167
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 2381-2389 (2023)
Erik WMA Bischoff,1 Nikki Ariens,1 Lonneke Boer,2 Jan Vercoulen,2 Reinier P Akkermans,1 Lisette van den Bemt,1 Tjard R Schermer1,3 1Radboud Institute for Health Sciences, Department of Primary and Community Care, Radboud University Medical Center, Ni
Externí odkaz:
https://doaj.org/article/5452f89073e44c31a64771509d02306b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.